Copegus - Genentech
... Safety and efficacy data are not available for treatment longer than 48 weeks. The safety and efficacy of COPEGUS and PEGASYS therapy have not been established in liver or other organ transplant recipients, patients with decompensated liver disease, or previous non-responders to interferon therapy. ...
... Safety and efficacy data are not available for treatment longer than 48 weeks. The safety and efficacy of COPEGUS and PEGASYS therapy have not been established in liver or other organ transplant recipients, patients with decompensated liver disease, or previous non-responders to interferon therapy. ...
The red skin syndromes: corticosteroid addiction and
... perioral dermatitis or contact dermatitis. After appropriate dermatological and medical evaluations, only one parameter of treatment was used in all patients – total and absolute cessation of topical and systemic corticosteroids. Only ‘supportive’ care was given for pruritus, pain, erythema, infecti ...
... perioral dermatitis or contact dermatitis. After appropriate dermatological and medical evaluations, only one parameter of treatment was used in all patients – total and absolute cessation of topical and systemic corticosteroids. Only ‘supportive’ care was given for pruritus, pain, erythema, infecti ...
Evaluation and Prognosis of Patients with Cirrhosis
... Illicit Drug Use Other than Alcohol: Ongoing illicit drug use must be addressed. A patient continuing to use illicit drugs, particularly injection drugs, remains at risk for other bloodborne viruses and their access to HCV treatment will be limited. In addition, daily marijuana use has been associat ...
... Illicit Drug Use Other than Alcohol: Ongoing illicit drug use must be addressed. A patient continuing to use illicit drugs, particularly injection drugs, remains at risk for other bloodborne viruses and their access to HCV treatment will be limited. In addition, daily marijuana use has been associat ...
The interaction between OSA and hypertension
... cardiovascular risk factors, a 12 mmHg reduction in systolic blood pressure (SBP) over ten years will prevent one death for every eleven patients treated. JNC 7 identifies a series of public health and community approaches that will contribute to reducing blood pressure in the population. It suggest ...
... cardiovascular risk factors, a 12 mmHg reduction in systolic blood pressure (SBP) over ten years will prevent one death for every eleven patients treated. JNC 7 identifies a series of public health and community approaches that will contribute to reducing blood pressure in the population. It suggest ...
Conscious Sedation:
... or renal function and increased depots of fatsoluble drugs. Consider reduced doses. Pediatric patients, particularly those under 6 month, exhibit increased sensitivity to opioids because of immature blood-brain barrier and ...
... or renal function and increased depots of fatsoluble drugs. Consider reduced doses. Pediatric patients, particularly those under 6 month, exhibit increased sensitivity to opioids because of immature blood-brain barrier and ...
Editor Assistant Editor Editorial Assistant Editorial Consultant
... confirmation from the relevant CEO’s office that the hospital in question did not have a local REC. Irish Journal of Medical Science • Volume 173 • Number 2 ...
... confirmation from the relevant CEO’s office that the hospital in question did not have a local REC. Irish Journal of Medical Science • Volume 173 • Number 2 ...
Tramadol HCL has Promise in On-Demand Use to Treat Premature
... Introduction. Premature ejaculation (PE) is a worldwide problem without an approved treatment. Selective serotonin reuptake inhibitors (SSRIs) are widely used “off label” as pharmacotherapeutic agents in the treatment of PE. Aim. This study investigates Tramadol efficacy for on-demand treatment of PE ...
... Introduction. Premature ejaculation (PE) is a worldwide problem without an approved treatment. Selective serotonin reuptake inhibitors (SSRIs) are widely used “off label” as pharmacotherapeutic agents in the treatment of PE. Aim. This study investigates Tramadol efficacy for on-demand treatment of PE ...
cardiology patient page
... Correspondence to Gervasio A. Lamas, MD, FAHA, Columbia University Division of Cardiology, Mount Sinai Medical Center, 4300 Alton Rd, Ste ...
... Correspondence to Gervasio A. Lamas, MD, FAHA, Columbia University Division of Cardiology, Mount Sinai Medical Center, 4300 Alton Rd, Ste ...
Featured Cases: What Does CFTR Tell Us About Lung Disease?
... right away. Some patients feel better as soon as they start taking it, but for the most part, patients notice the effect of the drug over time. And at this time we have to recommend that she continue all of her other medications, her airway clearance, inhaled antibiotics, ...
... right away. Some patients feel better as soon as they start taking it, but for the most part, patients notice the effect of the drug over time. And at this time we have to recommend that she continue all of her other medications, her airway clearance, inhaled antibiotics, ...
AFREZZA® | Inhaled Insulin | Fast Acting Insulin | A1C Control
... AFREZZA causes a decline in lung function over time as measured by FEV1. In clinical trials excluding patients with chronic lung disease and lasting up to 2 years, AFREZZAtreated patients experienced a small [40 mL (95% CI: -80, -1)] but greater FEV1 decline than comparator-treated patients. The FEV ...
... AFREZZA causes a decline in lung function over time as measured by FEV1. In clinical trials excluding patients with chronic lung disease and lasting up to 2 years, AFREZZAtreated patients experienced a small [40 mL (95% CI: -80, -1)] but greater FEV1 decline than comparator-treated patients. The FEV ...
Subdural hematoma cases identified through a Danish patient
... Purpose This study aimed to assess the usefulness of Danish patient registers for epidemiological studies of subdural hematoma (SDH) and to describe clinical characteristics of validated cases. Methods Using a patient register covering a geographically defined area in Denmark, we retrieved hospital c ...
... Purpose This study aimed to assess the usefulness of Danish patient registers for epidemiological studies of subdural hematoma (SDH) and to describe clinical characteristics of validated cases. Methods Using a patient register covering a geographically defined area in Denmark, we retrieved hospital c ...
Facts about the Medical Board August 25, 2010
... care complaints that do not appear to warrant intervention via formal disciplinary action. QIP focuses on cases in which poor practice patterns are beginning to emerge or the licensee has failed to keep up with changes in practice standards. With a successful intervention, the licensee benefits by i ...
... care complaints that do not appear to warrant intervention via formal disciplinary action. QIP focuses on cases in which poor practice patterns are beginning to emerge or the licensee has failed to keep up with changes in practice standards. With a successful intervention, the licensee benefits by i ...
Lamisil Singeldos cutaneous solution ENG SmPC
... application. It is therefore recommended to apply Lamisil Singeldos after a shower or bath and wait until the same time the following day before washing the feet gently again; after washing, the feet should be gently patted dry. Patients should use the quantity they need to cover both feet as instru ...
... application. It is therefore recommended to apply Lamisil Singeldos after a shower or bath and wait until the same time the following day before washing the feet gently again; after washing, the feet should be gently patted dry. Patients should use the quantity they need to cover both feet as instru ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights
... and Clinical Pharmacology (12.1, 12.2)]. OCREVUS has not been studied in combination with other MS therapies. Vaccinations Administer all immunizations according to immunization guidelines at least 6 weeks prior to initiation of OCREVUS. The safety of immunization with live or live-attenuated vaccin ...
... and Clinical Pharmacology (12.1, 12.2)]. OCREVUS has not been studied in combination with other MS therapies. Vaccinations Administer all immunizations according to immunization guidelines at least 6 weeks prior to initiation of OCREVUS. The safety of immunization with live or live-attenuated vaccin ...
Factors predicting response to splenectomy in adult patients with
... between diagnosis and splenectomy, and the response to high-dose intravenous Ig or corticosteroid therapy), but only the initial response to corticosteroid therapy was associated with more successful splenectomy (p < 0.05). The results published in the literature are contradictory and mainly based o ...
... between diagnosis and splenectomy, and the response to high-dose intravenous Ig or corticosteroid therapy), but only the initial response to corticosteroid therapy was associated with more successful splenectomy (p < 0.05). The results published in the literature are contradictory and mainly based o ...
The Clinical Case for Individualized Use of Proton
... living cancer-free and with excellent quality of life. The five-year freedom from biochemical and clinical progression rates were 99 percent, 99 percent, and 76 percent for low-risk, intermediate-risk, and high-risk patients, respectively. There was also low severe complication rate using proton bea ...
... living cancer-free and with excellent quality of life. The five-year freedom from biochemical and clinical progression rates were 99 percent, 99 percent, and 76 percent for low-risk, intermediate-risk, and high-risk patients, respectively. There was also low severe complication rate using proton bea ...
Guidelines for intensive care unit design
... Persistent shortages of skilled staff and aging of the critical care staff (12) have added new criteria for selecting technology and for making ICU design decisions (13, 14). ...
... Persistent shortages of skilled staff and aging of the critical care staff (12) have added new criteria for selecting technology and for making ICU design decisions (13, 14). ...
bringing down the cost of glaucoma treatment with slt
... respectively, even if SLT needs to be repeated in two years’ time.12 The savings were greater if SLT did not need to be repeated for three years following the initial treatment. Furthermore, an economic study from the Centre for Eye Research Australia (CERA) found that the order of treatment options ...
... respectively, even if SLT needs to be repeated in two years’ time.12 The savings were greater if SLT did not need to be repeated for three years following the initial treatment. Furthermore, an economic study from the Centre for Eye Research Australia (CERA) found that the order of treatment options ...
Chronic Myeloid Leukemia Clinical Practice ... (Malaysia) Chairman
... Though both nilotinib and dasatinib have been approved by FDA for frontline treatment of newly diagnosed CML, imatinib would still be the recommended drug as very few patients unassisted can afford the second generation TKIs which appear to achieve higher and faster rate of disease response4 (cytoge ...
... Though both nilotinib and dasatinib have been approved by FDA for frontline treatment of newly diagnosed CML, imatinib would still be the recommended drug as very few patients unassisted can afford the second generation TKIs which appear to achieve higher and faster rate of disease response4 (cytoge ...
Hypotension in renal failure patients undergoing dialysis therapy
... Owens and O’Brien [2] assessed hypotension prevalence from a 24-hour blood pressure measurement in healthy individuals, the diagnostic criterion being the systolic blood pressure <115 mmHg at daytime and <70 mmHg at night, and the diastolic blood pressure <97 mmHg at daytime and <56 mmHg at night in ...
... Owens and O’Brien [2] assessed hypotension prevalence from a 24-hour blood pressure measurement in healthy individuals, the diagnostic criterion being the systolic blood pressure <115 mmHg at daytime and <70 mmHg at night, and the diastolic blood pressure <97 mmHg at daytime and <56 mmHg at night in ...
... which was approximately twice that of a MDI, with less variability. The authors suggested that a less wellcontrolled inhalation procedure than that used in their study could have resulted in a greater difference between the two devices. This suggestion is confirmed by clinical studies showing that b ...
Patient-Reported Outcomes in Left Ventricular Assist Device Therapy
... distress, psychological morbidity, and psychosocial. Only full-text empirical studies with a sample size ⱖ10, examining the impact of LVAD therapy on PROs assessed by standardized clinical interviews or standardized and validated questionnaires, were eligible for inclusion. Articles found by referen ...
... distress, psychological morbidity, and psychosocial. Only full-text empirical studies with a sample size ⱖ10, examining the impact of LVAD therapy on PROs assessed by standardized clinical interviews or standardized and validated questionnaires, were eligible for inclusion. Articles found by referen ...
Thyroid Gland and Anesthetic Management
... Pregnant females should be treated with propylthiouracil (of antithyroid drugs it crosses placenta least), minimizing the risk of goiter any hypothyroidism in fetus Serious side effects of antithyroid drugs include agranulocytosis Intraoperative bleeding, from drug-induced thrombocytopenia or hy ...
... Pregnant females should be treated with propylthiouracil (of antithyroid drugs it crosses placenta least), minimizing the risk of goiter any hypothyroidism in fetus Serious side effects of antithyroid drugs include agranulocytosis Intraoperative bleeding, from drug-induced thrombocytopenia or hy ...
Yohimbine in the treatment of orgasmic dysfunction
... to monitor any increase in blood pressure. Yohimbine was given at the dose of 20 mg p.o. by tablet in most men but three men were treated with yohimbine microenema by one of the authors. The latter route was used when the patient had recently eaten, because absorption of yohimbine is slower and more ...
... to monitor any increase in blood pressure. Yohimbine was given at the dose of 20 mg p.o. by tablet in most men but three men were treated with yohimbine microenema by one of the authors. The latter route was used when the patient had recently eaten, because absorption of yohimbine is slower and more ...